Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LHX vs GSK✓SelectedUSD · GSKLHX vs GSK performance historyLatest closeAs of-0.39%11/17
Stock and ETF performance explorer

LHX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+7,831.4%
GSK return
+1,698.4%
Excess return
+6,133.1%
Maximum drawdown
-60.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.4%-2.3%+1.9%+0.3%
7D-5.5%-3.0%-2.5%-4.7%
30D+4.9%+0.4%+4.6%+4.6%
3M-5.9%-1.2%-4.7%-5.9%
6M-13.3%+0.9%-14.2%-13.9%
YTD-10.1%+4.0%-14.1%-11.8%
1Y-8.2%+7.3%-15.5%-10.9%
3Y+47.8%+57.1%-9.2%+25.8%
5Y+30.2%+43.0%-12.7%+12.3%
10Y+201.3%+103.1%+98.3%+132.9%
All+7,831.4%+1,698.4%+6,133.1%+3,666.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling